ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$21,070
-63.1%
235,204
-65.0%
0.02%
-63.8%
Q2 2023$57,145
+4.5%
671,185
+1.5%
0.07%
-2.8%
Q1 2023$54,702
+10.9%
661,048
+5.4%
0.07%
+2.9%
Q4 2022$49,339
-99.6%
627,318
+262.9%
0.07%
+263.2%
Q3 2022$12,797,000
+483.0%
172,859
+413.3%
0.02%
+533.3%
Q2 2022$2,195,000
-49.7%
33,678
-14.3%
0.00%
-50.0%
Q1 2021$4,363,000
+1480.8%
39,300
+1588.1%
0.01%
Q4 2020$276,000
-98.1%
2,328
-98.6%
0.00%
-100.0%
Q3 2020$14,327,000
-22.7%
164,202
-20.6%
0.02%
-32.4%
Q2 2020$18,533,000
+761.6%
206,933
+1057.8%
0.03%
+580.0%
Q2 2019$2,151,000
-0.0%
17,873
-27.3%
0.01%0.0%
Q1 2019$2,152,000
-90.0%
24,600
-86.9%
0.01%
-89.8%
Q3 2018$21,524,000
-45.4%
187,848
-57.2%
0.05%
-49.0%
Q2 2018$39,395,000
+542.0%
439,282
+423.8%
0.10%
+585.7%
Q1 2018$6,136,000
-11.7%
83,870
-45.8%
0.01%
-26.3%
Q3 2017$6,949,000
+13.6%
154,861
+0.0%
0.02%0.0%
Q2 2017$6,115,000154,8560.02%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders